Grade: Pharmaceutical Grade

Factory Location: Shandong

Main Sales Markets: North America,Western Europe,Eastern Europe,Asia,Middle East

Monthly Production Capacity: 100kg

Contract Manufacturing: CRO,CMO

Packaging Information: 5kg/drum

Delivery Lead Time: 15days

Sample Provided: yes

Payment Terms: L/C

Lenvatinib mesylate857890-39-2

Product Name: lenvatinib Mesylate

Synonyms: lenvatinib Methanesulfonate;E7080 Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate;4-[3chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate;CAT#A863437;Lenvatinib Mesylate,Chemical offer CAS#857890-39-2;lenvatinib Mesylate;E7080;E-7080;E 7080CAS: 857890-39-2

MF: C22H23ClN4O7

SMW: 522.95862

EINECS: 812-398-0

Lenvatinib Mesylate is a synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. E7080 blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.